Yongzhi Cui

14.4k citations

44 papers · 9.1k indexed · 4 hit papers · h-index 28

Immunology top 0.2%
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 5
Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions 9
- CAR-T cell therapy research 8
- Bone health and treatments 3
Hematology top 2%
Genetics top 1%
Cancer Research top 5%
Molecular Biology
- Extracellular vesicles in disease 5

Co-authors: Lothar Hennighausen Crystal L. Mackall Batu Erman Amala Alag Alfred Singer Stanley Adoro Terry I. Guinter Masato Kubo
Cited by: Immunology Oncology Hematology
Journals: Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States China Japan

In The Last Decade

Yongzhi Cui

43 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 Redox Biology
2014 The Lancet
2014 Science Translational Medicine
2010 Nature Immunology

Peers

Countries citing papers authored by Yongzhi Cui

Since Specialization

Citations

This map shows the geographic impact of Yongzhi Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongzhi Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongzhi Cui more than expected).

Fields of papers citing papers by Yongzhi Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongzhi Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongzhi Cui. The network helps show where Yongzhi Cui may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yongzhi Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yongzhi Cui Line = papers co-authored together Yongzhi Cui links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dual-target nanotherapy for vascular endothelium and bone mesenchymal stem cells halt steroid-induced osteonecrosis of the femoral head progression Journal of Controlled Release ·Wenbo Yang,Qing Pan,Yizhong Peng,Yuxiang Hu,Yongzhi Cui,Zengwu Shao,Chunqing Meng,Hong Wang,Wei Huang	2025	3
2	Sirt3-mediated mitophagy regulates AGEs-induced BMSCs senescence and senile osteoporosisbreakdown → Redox Biology ·Yuanyuan Guo,Xiong Jia,Yongzhi Cui,Yu Song,Siyuan Wang,Yongtao Geng,Rui Li,Weihang Gao,Dehao Fu	2021	204
3	Remote-controllable bone-targeted delivery of estradiol for the treatment of ovariectomy-induced osteoporosis in rats Journal of Nanobiotechnology ·Yuanyuan Guo,Yongwei Liu,Chen Shi,Tingting Wu,Yongzhi Cui,Siyuan Wang,Ping Liu,Xiaobo Feng,Yu He,Dehao Fu	2021	25
4	A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis Bioactive Materials ·Yongzhi Cui,Yuanyuan Guo,Li Kong,Jingyu Shi,Ping Liu,Rui Li,Yongtao Geng,Weihang Gao,Zhiping Zhang,Dehao Fu	2021	172
5	Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas Frontiers in Immunology ·Massimo Fantini,Justin M. David,Olga Saric,Alexander Dubeykovskiy,Yongzhi Cui,Sharon Mavroukakis,Andrew Bristol,Christina M. Annunziata,Kwong Y. Tsang,Philip M. Arlen	2018	16
6	Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas Cancer Immunology Research ·Adrienne H. Long,Steven L. Highfill,Yongzhi Cui,Jillian Smith,Alec J. Walker,Sneha Ramakrishna,Rana El-Etriby,Susana Galli,Maria Tsokos,Rimas J. Orentas,Crystal L. Mackall	2016	258
7	T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialbreakdown → The Lancet ·Daniel W Lee,James N. Kochenderfer,Maryalice Stetler‐Stevenson,Yongzhi Cui,Cindy Delbrook,Steven A. Feldman,Terry J. Fry,Rimas J. Orentas,Marianna Sabatino,Nirali N. Shah,Seth M. Steinberg,D. Stroncek,Nicholas Tschernia,Constance M. Yuan,Hua Zhang,Ling Zhang,Steven A. Rosenberg,Alan S. Wayne,Crystal L. Mackall	2014	2154
8	Val-BoroPro Accelerates T Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors PLoS ONE ·Meghaan P. Walsh,Brynn B. Duncan,Shannon M. Larabee,Aviva C. Krauss,Jessica P.E. Davis,Yongzhi Cui,Su Young Kim,Martin Guimond,William W. Bachovchin,Terry J. Fry	2013	41
9	Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells Journal of Immunotherapy ·Hua Zhang,Yongzhi Cui,Nga Voong,Marianna Sabatino,D. Stroncek,Sebastien Morisot,Curt I. Civin,Alan S. Wayne,Bruce L. Levine,Crystal L. Mackall	2011	43
10	Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cellsbreakdown → Nature Immunology ·Jung‐Hyun Park,Stanley Adoro,Terry I. Guinter,Batu Erman,Amala Alag,Marta Catálfamo,Motoko Y. Kimura,Yongzhi Cui,Philip J. Lucas,Ronald E. Gress,Masato Kubo,Lothar Hennighausen,Lionel Feigenbaum,Alfred Singer	2010	2928
11	Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells Nature Immunology ·Martin Guimond,Rachelle G. Veenstra,David J. Grindler,Hua Zhang,Yongzhi Cui,Ryan Murphy,Su Young Kim,Risu Na,Lothar Hennighausen,Sema Kurtuluş,Batu Erman,Polly Matzinger,Melinda S. Merchant,Crystal L. Mackall	2009	174
12	Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals The Journal of Experimental Medicine ·Alejandro V. Villarino,Cristina M. Tato,Jason S. Stumhofer,Zhengju Yao,Yongzhi Cui,Lothar Hennighausen,John J. O’Shea,Christopher A. Hunter	2007	105
13	STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output Experimental Hematology ·Geqiang Li,Zhengqi Wang,Yi Zhang,Zizhen Kang,Eleonora Haviernikova,Yongzhi Cui,Lothar Hennighausen,Richard Moriggl,Demin Wang,William Ka Fai Tse,Kevin D. Bunting	2007	35
14	Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration† Hepatology ·Yongzhi Cui,Atsushi Hosui,Rui Sun,Kezhen Shen,Oksana Gavrilova,Weiping Chen,Margaret C. Cam,Bin Gao,Gertraud W. Robinson,Lothar Hennighausen	2007	149
15	Stat5a/b are essential for normal lymphoid development and differentiation Proceedings of the National Academy of Sciences ·Zhengju Yao,Yongzhi Cui,Wendy T. Watford,Jay H. Bream,Kunihiro Yamaoka,Bruce D. Hissong,Denise Li,Scott K. Durum,Qiong Jiang,Avinash Bhandoola,Lothar Hennighausen,John J. O’Shea	2006	285
16	Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation Blood ·Andrea Hoelbl‐Kovacic,Boris Kovačic,Marc A. Kerenyi,Olivia Simma,Wolfgang Warsch,Yongzhi Cui,Hartmut Beug,Lothar Hennighausen,Richard Moriggl,Veronika Sexl	2006	168
17	Overexpression of the Tumor Suppressor Gene Phosphatase and Tensin Homologue Partially Inhibits Wnt-1–Induced Mammary Tumorigenesis Cancer Research ·Hong Zhao,Yongzhi Cui,Joëlle Dupont,Hui Sun,Lothar Hennighausen,Shoshana Yakar	2005	31
18	Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease Gastroenterology ·Josep Bassaganya‐Riera,Kathryn Reynolds,Susan Martino‐Catt,Yongzhi Cui,Lothar Hennighausen,Frank J. Gonzalez,James E. Rohrer,Alejandro Uribe Benninghoff,Raquel Hontecillas	2004	316
19	Loss of the Peroxisome Proliferation-activated Receptor gamma (PPARγ) Does Not Affect Mammary Development and Propensity for Tumor Formation but Leads to Reduced Fertility Journal of Biological Chemistry ·Yongzhi Cui,Keiko Miyoshi,Estefanı́a Claudio,Ulrich Siebenlist,Frank J. Gonzalez,Jodi A. Flaws,Kay‐Uwe Wagner,Lothar Hennighausen	2002	161
20	Structure of the Mouse Stat 3/5 Locus: Evolution from Drosophila to Zebrafish to Mouse Genomics ·Keiko Miyoshi,Yongzhi Cui,Gregory Riedlinger,Phyllis R. Robinson,Jessica A. Lehoczky,Leonard I. Zon,Takami Oka,Ken Dewar,Lothar Hennighausen	2001	51

About Yongzhi Cui

Yongzhi Cui is a scholar working on Immunology, Oncology and Orthopedics and Sports Medicine, having authored 44 papers that have together received 9.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (12 papers), Cytokine Signaling Pathways and Interactions (9 papers), CAR-T cell therapy research (8 papers), T-cell and B-cell Immunology (6 papers), Immunotherapy and Immune Responses (5 papers), Extracellular vesicles in disease (5 papers), Immune cells in cancer (5 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Immunology (4.8k citations), Oncology (4.2k citations) and Hematology (592 citations). Yongzhi Cui has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Lothar Hennighausen, Crystal L. Mackall, Batu Erman, Amala Alag, Alfred Singer, Stanley Adoro, Terry I. Guinter, Masato Kubo, Lionel Feigenbaum and Philip J. Lucas. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact